Wave Life Sciences (WVE) EBT Margin: 2015-2025
Historic EBT Margin for Wave Life Sciences (WVE) over the last 7 years, with Jun 2025 value amounting to -580.17%.
- Wave Life Sciences' EBT Margin fell 41298.00% to -580.17% in Q2 2025 from the same period last year, while for Jun 2025 it was -259.21%, marking a year-over-year decrease of 19209.00%. This contributed to the annual value of -89.57% for FY2024, which is 3821.00% down from last year.
- Per Wave Life Sciences' latest filing, its EBT Margin stood at -580.17% for Q2 2025, which was down 13.55% from -510.93% recorded in Q1 2025.
- Over the past 5 years, Wave Life Sciences' EBT Margin peaked at 13.36% during Q3 2023, and registered a low of -13,685.61% during Q3 2022.
- Moreover, its 3-year median value for EBT Margin was -189.58% (2023), whereas its average is -232.50%.
- Its EBT Margin has fluctuated over the past 5 years, first slumped by 1,366,851bps in 2022, then spiked by 1,369,897bps in 2023.
- Wave Life Sciences' EBT Margin (Quarterly) stood at -1,982.38% in 2021, then slumped by 149,042bps to -3,472.80% in 2022, then spiked by 341,685bps to -55.95% in 2023, then plummeted by 7,172bps to -167.19% in 2024, then crashed by 41,298bps to -580.17% in 2025.
- Its last three reported values are -580.17% in Q2 2025, -510.93% for Q1 2025, and -167.19% during Q2 2024.